Currently accepted at: JMIR Research Protocols
Date Submitted: Feb 10, 2026
Date Accepted: Oct 7, 2026
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/93248
The final accepted version (not copyedited yet) is in this tab.
Digital rehabilitation (eCALAP) and music listening for aphasia: a single-case experimental design study protocol
ABSTRACT
Background:
Aphasia, a language impairment caused by stroke, affects daily life and impedes autonomy. Recent advances indicate that personalized, targeted language therapy yields better outcomes than conventional approaches, and that higher therapy intensity improves recovery. Access to individualized and intensive rehabilitation nevertheless remains limited by logistical and clinical barriers, and no available digital tool derives an individually targeted therapy plan from a theoretically motivated assessment of the impaired language components. In parallel, music listening has emerged as a complementary approach, with studies suggesting it can enhance cognitive and emotional recovery post-stroke, yet its added value alongside targeted language therapy remains untested. The eCALAP digital tool we developed addresses these gaps by delivering personalized, targeted therapy and self-rehabilitation sessions that increase intensity.
Objective:
Two studies are reported. SCED-1 evaluates the effect of the eCALAP-rehabilitation program on language performance in post-stroke aphasia. SCED-2 evaluates the effect of adding daily music listening to that program, which is delivered at the same frequency in both phases. In each study, the secondary objective is to determine whether gains extend beyond the trained tasks to narrative discourse.
Methods:
Two non-concurrent multiple-baseline single-case experimental designs (SCEDs) will each include at least five participants with post-stroke aphasia. In both SCEDs, repeated measures are collected three times a week throughout the protocol: using a picture naming task, sentence comprehension task and word or non-word repetition task. In SCED-1, a baseline phase of randomized length (5 to 9 measurement points, 2–3 weeks), during which no oral language rehabilitation is provided, is followed by an intervention phase of 10 sessions over 3 weeks based on a personalized plan generated by the eCALAP-rehabilitation tool, supplemented by tablet-based self-rehabilitation exercises logged by the application. In SCED-2, participants receive eCALAP-rehabilitation alone during a randomized baseline phase (5 to 9 points), then continue it while also engaging in daily passive music listening (≥1 hour/day) through a dedicated Spotify account during the 10-session intervention phase. Analyses combine conservative dual-criterion visual analysis, exact randomization tests on the randomized intervention start points at the group level, and Tau-U and NAP effect sizes computed per participant and outcome.
Results:
The study obtained funding and received ethical approval in 2023. Recruitment started in August 2024 and as of February 2026 8 participants have been enrolled, 6 of whom have completed the protocol. Data collection is expected to end in June 2027.
Conclusions:
By using a digital tool to personalize and intensify therapy, and by integrating music listening as a potential enhancer, we address current limitations in aphasia care. If effective, the results could support the incorporation of music listening into standard rehabilitation protocols and promote broader access to individualized digital therapy. Clinical Trial: NCT06817642 (First Posted 2025-02-10); APHP220542
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.